NCT00633191View on ClinicalTrials.gov

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Cystic FibrosisInfectionPseudomonas Aeruginosa
Interventions
DRUG

Anti-pseudomonas IgY gargle

Gargle (solution), \> 5FKU, every night after toothbrushing, life-long

Trial Locations (1)

SE-751 85

Cystic fibrosis centre,Children´s University Hospital, Uppsala

All Listed Sponsors
lead

Immunsystem AB

OTHER

NCT00633191 - Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis | Biotech Hunter | Biotech Hunter